Oxford Biodynamics, Holos Partner Up On Concussion
Executive Summary
Oxford Biodynamics and Holos Life Sciences are putting their heads together to develop noninvasive epigenetic biomarkers for sports-related concussions. The analysis aims to identify biomarkers that potentially could be monitored and improve athlete rehabilitation.